Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Sep 16, 2014

Mylan Commences Phase III Clinical Trials for its Generic Version of Advair Diskus® and Insulin Analog to Lantus®

Sep 15, 2014

Mylan Signs Agreement with Gilead to Accelerate Access to Hepatitis C Treatments, Sovaldi® (Sofosbuvir) and Single Tablet Regimen of Ledipasvir/Sofosbuvir, in Developing Countries

Sep 10, 2014

Mylan to Acquire U.S. Rights to Arixtra® (fondaparinux sodium) Injection from Aspen

Sep 08, 2014

Court Grants Summary Judgment in Favor of Mylan and FDA Related to Generic Precedex™

Sep 05, 2014

Mylan Launches Generic Boniva® Injection

Aug 28, 2014

Mylan's ANDA for Three Times Per Week Generic Copaxone® 40 mg/mL Accepted for Filing by FDA

Aug 25, 2014

Ready2Go™ Draft Winners Join Pro Football MVP Adrian Peterson in Educational Video About Anaphylaxis Preparedness

Aug 22, 2014

Mylan Launches First Generic Klor-Con® Extended-Release Tablets

Aug 19, 2014

Mylan Launches Generic Precedex™ Injection - Another Key Product Approval

Aug 11, 2014

Mylan Launches Generic Xeloda® Tablets

Pagination

First page
Previous page
…
Page 41
Page 42
Page 43
Page 44
Current page 45
Page 46
Page 47
Page 48
Page 49
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2024 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.